MedTrace Logo

Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet

NCT04965129 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-05-17

No results posted yet for this study

Summary

This study is conducted to test the hypothesis that patients with lung cancer undergoing treatment with immunotherapy, chemotherapy and tyrosine Kinase Inhibitors receiving a high protein diet and supplemented with fish oil will improve muscle mass, therapeutic response and modulate the intestinal microbiota within a 4 month period.

Conditions

Interventions

DRUG

Placebo

Drug: Placebo olive oil pill manufactured to mimic fish oil. Other Names: • Placebo

DRUG

Fish oil

All subjects will be given fish oil with a dose of of 2.100 mg of EPA and 924 mg of DHA, in four tablet twice daily for four mounths.

Sponsors & Collaborators

  • Institutos Madrileño de Estudios Avanzados IMDEA

    collaborator UNKNOWN

  • Oncoclínicas

    collaborator INDUSTRY

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Wilza AF Peres, PhD · Post-graduation in Nutrition, Institute of Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2024-05-31
Completion
2025-03-15

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04965129 on ClinicalTrials.gov